Syngene International Ltd.

Syngene International Ltd.


Company description

Syngene International Limited, (BSE code: 539268, NSE Id: SYNGENE, ISIN Id: INE398R01022) is India’s largest Contract Research Organization offering a suite of integrated, end-to-end discovery, development and manufacturing services for novel molecular entities across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies.

Our service offerings in discovery and development cover multiple domains across small molecules, large molecules, antibody-drug conjugates (“ADC”) and oligonucleotides. Our integrated discovery and development platforms help organizations conduct discovery (from hit to candidate selection), development (including pre-clinical and clinical studies, analytical and bio-analytical evaluation, formulation development and stability studies) and pilot manufacturing (scale-up, pre-clinical and clinical supplies) with a distinctive economic advantage. We are also in the process of setting up a large scale manufacturing facility at Mangalore to strengthen our commercial manufacturing services.

Syngene brings together a state-of-the-art infrastructure spread across 1.3 Mn sq. ft. and a highly experienced team of about 3100 scientists, to help R&D focused organizations achieve better R&D efficiency and reduce development time. For more details, visit

Quick facts

Sales markets Western Europe, Eastern Europe, Middle East, Asia, Australia, North America, Central/South America
Affiliated categories: API Contract Manufacturing |Biopharmaceuticals (general category) |Clinical Research (Field) More

Meet us at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain Visit us at stand 3C100 Book a meeting See our Exhibitor Profile

News about Syngene International Ltd.

Syngene International Announces Broadening of Research Collaboration with Amgen Inc.

9 Oct 2017

Syngene International Announces Broadening of Research Collaboration with Amgen Inc.

With the expansion, the floor space of Syngene Amgen Research & Development Center will double to 50,000 sq. ft. A team of up to 185 multi-disciplinary Syngene scientists will work in the areas of medicinal and process chemistry, biologics, bioprocess development, drug metabolism, pharmacokinetics, bioanalytical research and pharmaceutical development.

Read more
Syngene International Ltd.

Contact information




View all contact information